GKB Ophthalmics Limited (BOM:533212)
India · Delayed Price · Currency is INR 64.84
+1.14 (1.79%)
At close: Jun 4, 2026
GKB Ophthalmics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,491 | 1,090 | 882.54 | 754.75 | 709.38 |
Other Revenue | 22.45 | - | - | - | - |
| 1,513 | 1,090 | 882.54 | 754.75 | 709.38 | |
Revenue Growth (YoY) | 38.83% | 23.49% | 16.93% | 6.40% | 24.72% |
Cost of Revenue | 1,054 | 740.14 | 603.45 | 482.01 | 453.76 |
Gross Profit | 459.11 | 349.73 | 279.09 | 272.73 | 255.62 |
Selling, General & Admin | 161.07 | 201.46 | 162.23 | 132.94 | 111.53 |
Other Operating Expenses | 189.41 | 177.71 | 111.07 | 102.94 | 94.55 |
Operating Expenses | 382.85 | 410.04 | 302.29 | 264.17 | 232.76 |
Operating Income | 76.27 | -60.31 | -23.2 | 8.56 | 22.85 |
Interest Expense | -26.75 | -15.73 | -13.85 | -12.95 | -11.14 |
Interest & Investment Income | - | 10.75 | 8.89 | 6.02 | 5.12 |
Earnings From Equity Investments | -0.59 | 1.83 | -0.59 | 0.33 | 0.91 |
Currency Exchange Gain (Loss) | - | 1.92 | 0.16 | 1.27 | 2 |
Other Non Operating Income (Expenses) | - | -6.25 | -1.21 | -2.42 | -1.85 |
EBT Excluding Unusual Items | 48.94 | -67.79 | -29.79 | 0.81 | 17.9 |
Gain (Loss) on Sale of Investments | - | - | 0 | - | 0.07 |
Gain (Loss) on Sale of Assets | - | 0.4 | 0.45 | 0.57 | -0.42 |
Other Unusual Items | -17.9 | 0.13 | 1.59 | 0 | 0.06 |
Pretax Income | 31.04 | -67.26 | -27.76 | 1.39 | 19.46 |
Income Tax Expense | 0.77 | 3.53 | 2.06 | 0.23 | 0.02 |
Earnings From Continuing Operations | 30.27 | -70.79 | -29.82 | 1.16 | 19.44 |
Minority Interest in Earnings | -18.09 | 0.34 | 1.72 | -2.84 | -6.7 |
Net Income | 12.19 | -70.45 | -28.11 | -1.67 | 12.74 |
Net Income to Common | 12.19 | -70.45 | -28.11 | -1.67 | 12.74 |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | -0.12% | - | - | - | 0.01% |
EPS (Basic) | 2.42 | -13.98 | -5.58 | -0.33 | 2.53 |
EPS (Diluted) | 2.42 | -13.98 | -5.58 | -0.33 | 2.53 |
Free Cash Flow | -48.34 | -55.77 | 21.44 | -39.87 | 3.11 |
Free Cash Flow Per Share | -9.60 | -11.06 | 4.25 | -7.91 | 0.62 |
Gross Margin | 30.34% | 32.09% | 31.62% | 36.14% | 36.03% |
Operating Margin | 5.04% | -5.53% | -2.63% | 1.13% | 3.22% |
Profit Margin | 0.80% | -6.46% | -3.19% | -0.22% | 1.80% |
Free Cash Flow Margin | -3.19% | -5.12% | 2.43% | -5.28% | 0.44% |
EBITDA | 108.64 | -29.45 | 5.78 | 36.83 | 49.52 |
EBITDA Margin | 7.18% | -2.70% | 0.66% | 4.88% | 6.98% |
D&A For EBITDA | 32.37 | 30.86 | 28.98 | 28.27 | 26.66 |
EBIT | 76.27 | -60.31 | -23.2 | 8.56 | 22.85 |
EBIT Margin | 5.04% | -5.53% | -2.63% | 1.13% | 3.22% |
Effective Tax Rate | 2.47% | - | - | 16.57% | 0.12% |
Revenue as Reported | 1,513 | 1,103 | 897.6 | 763.98 | 720.92 |
Advertising Expenses | - | 6.31 | 4.65 | 2.68 | 1.32 |